Jefferies Group’s Intersect ENT, Inc XENT Stock Holding History

Jefferies Group’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31,600	Closed	-$909K	–	2731
2018 Q3	$909K	Buy	+31,600	New	+$949K	0.01%	1378

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jefferies Group's XENT Position: Q3 2019 in Review

Jefferies Group sold out of Intersect ENT, Inc (XENT) in Q3 2019, closing a stake of 27,124 shares — an estimated $617K sold.

Jefferies Group first reported a position in XENT in Q3 2018 and held it in 4 quarters. The position peaked at $617K in Q2 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2019.

Jefferies Group reported no remaining Intersect ENT, Inc position as of Q3 2019 after selling out during the quarter.
Jefferies Group sold 27,124 Intersect ENT, Inc shares in Q3 2019, an estimated $617K.
Jefferies Group first reported a position in Intersect ENT, Inc in Q3 2018 and held it in 4 quarters.
Jefferies Group's Intersect ENT, Inc position peaked at $617K in Q2 2019.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.